253 related articles for article (PubMed ID: 30962346)
21. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
Gupta S; Cohen KA; Winglee K; Maiga M; Diarra B; Bishai WR
Antimicrob Agents Chemother; 2014; 58(1):574-6. PubMed ID: 24126586
[TBL] [Abstract][Full Text] [Related]
22. TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.
Sarathy JP; Ragunathan P; Cooper CB; Upton AM; Grüber G; Dick T
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712198
[TBL] [Abstract][Full Text] [Related]
23. Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
Andries K; Villellas C; Coeck N; Thys K; Gevers T; Vranckx L; Lounis N; de Jong BC; Koul A
PLoS One; 2014; 9(7):e102135. PubMed ID: 25010492
[TBL] [Abstract][Full Text] [Related]
24. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
Ismail N; Omar SV; Ismail NA; Peters RPH
J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
[TBL] [Abstract][Full Text] [Related]
25.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
26. Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an
de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866874
[TBL] [Abstract][Full Text] [Related]
27. SAR study of piperidine derivatives as inhibitors of 1,4-dihydroxy-2-naphthoate isoprenyltransferase (MenA) from Mycobacterium tuberculosis.
Berg K; Hegde P; Pujari V; Brinkmann M; Wilkins DZ; Parish T; Crick DC; Aldrich CC
Eur J Med Chem; 2023 Mar; 249():115125. PubMed ID: 36682292
[TBL] [Abstract][Full Text] [Related]
28. Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
Zhang M; Sala C; Hartkoorn RC; Dhar N; Mendoza-Losana A; Cole ST
Antimicrob Agents Chemother; 2012 Nov; 56(11):5782-9. PubMed ID: 22926567
[TBL] [Abstract][Full Text] [Related]
29. Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery.
Roy KK; Wani MA
Expert Opin Drug Discov; 2020 Feb; 15(2):231-241. PubMed ID: 31774006
[No Abstract] [Full Text] [Related]
30. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
Gutiérrez AV; Richard M; Roquet-Banères F; Viljoen A; Kremer L
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332077
[No Abstract] [Full Text] [Related]
31. Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
Almeida D; Ioerger T; Tyagi S; Li SY; Mdluli K; Andries K; Grosset J; Sacchettini J; Nuermberger E
Antimicrob Agents Chemother; 2016 Aug; 60(8):4590-9. PubMed ID: 27185800
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium tuberculosis cysteine biosynthesis genes mec+-cysO-cysM confer resistance to clofazimine.
Burns-Huang K; Mundhra S
Tuberculosis (Edinb); 2019 Mar; 115():63-66. PubMed ID: 30948178
[TBL] [Abstract][Full Text] [Related]
33. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline.
Berney M; Hartman TE; Jacobs WR
mBio; 2014 Jul; 5(4):e01275-14. PubMed ID: 25028424
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
[TBL] [Abstract][Full Text] [Related]
35. Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death.
Heikal A; Hards K; Cheung CY; Menorca A; Timmer MS; Stocker BL; Cook GM
J Antimicrob Chemother; 2016 Oct; 71(10):2840-7. PubMed ID: 27365187
[TBL] [Abstract][Full Text] [Related]
36. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
Worley MV; Estrada SJ
Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
[TBL] [Abstract][Full Text] [Related]
37. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
[TBL] [Abstract][Full Text] [Related]
38. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
39. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
[TBL] [Abstract][Full Text] [Related]
40. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
